Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15023378rdf:typepubmed:Citationlld:pubmed
pubmed-article:15023378lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:15023378lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:15023378lifeskim:mentionsumls-concept:C0409959lld:lifeskim
pubmed-article:15023378lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:15023378lifeskim:mentionsumls-concept:C0008466lld:lifeskim
pubmed-article:15023378lifeskim:mentionsumls-concept:C0205267lld:lifeskim
pubmed-article:15023378lifeskim:mentionsumls-concept:C1696465lld:lifeskim
pubmed-article:15023378lifeskim:mentionsumls-concept:C1096776lld:lifeskim
pubmed-article:15023378pubmed:issue4lld:pubmed
pubmed-article:15023378pubmed:dateCreated2004-3-16lld:pubmed
pubmed-article:15023378pubmed:abstractTextTo investigate the efficacy and tolerability of a 3-month duration, twice a-year, intermittent treatment with oral chondroitin sulfate (CS) in knee osteoarthritis (OA) patients.lld:pubmed
pubmed-article:15023378pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15023378pubmed:languageenglld:pubmed
pubmed-article:15023378pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15023378pubmed:citationSubsetIMlld:pubmed
pubmed-article:15023378pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15023378pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15023378pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15023378pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15023378pubmed:statusMEDLINElld:pubmed
pubmed-article:15023378pubmed:monthAprlld:pubmed
pubmed-article:15023378pubmed:issn1063-4584lld:pubmed
pubmed-article:15023378pubmed:authorpubmed-author:MarcolongoRob...lld:pubmed
pubmed-article:15023378pubmed:authorpubmed-author:VignonEricElld:pubmed
pubmed-article:15023378pubmed:authorpubmed-author:MalaiseMichel...lld:pubmed
pubmed-article:15023378pubmed:authorpubmed-author:FioravantiAnt...lld:pubmed
pubmed-article:15023378pubmed:authorpubmed-author:UebelhartDani...lld:pubmed
pubmed-article:15023378pubmed:authorpubmed-author:PipernoMuriel...lld:pubmed
pubmed-article:15023378pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:15023378pubmed:authorpubmed-author:DeVathaireFlo...lld:pubmed
pubmed-article:15023378pubmed:authorpubmed-author:MailleuxElisa...lld:pubmed
pubmed-article:15023378pubmed:authorpubmed-author:MatosoLuisLlld:pubmed
pubmed-article:15023378pubmed:issnTypePrintlld:pubmed
pubmed-article:15023378pubmed:volume12lld:pubmed
pubmed-article:15023378pubmed:ownerNLMlld:pubmed
pubmed-article:15023378pubmed:authorsCompleteYlld:pubmed
pubmed-article:15023378pubmed:pagination269-76lld:pubmed
pubmed-article:15023378pubmed:dateRevised2007-10-4lld:pubmed
pubmed-article:15023378pubmed:meshHeadingpubmed-meshheading:15023378...lld:pubmed
pubmed-article:15023378pubmed:meshHeadingpubmed-meshheading:15023378...lld:pubmed
pubmed-article:15023378pubmed:meshHeadingpubmed-meshheading:15023378...lld:pubmed
pubmed-article:15023378pubmed:meshHeadingpubmed-meshheading:15023378...lld:pubmed
pubmed-article:15023378pubmed:meshHeadingpubmed-meshheading:15023378...lld:pubmed
pubmed-article:15023378pubmed:meshHeadingpubmed-meshheading:15023378...lld:pubmed
pubmed-article:15023378pubmed:meshHeadingpubmed-meshheading:15023378...lld:pubmed
pubmed-article:15023378pubmed:meshHeadingpubmed-meshheading:15023378...lld:pubmed
pubmed-article:15023378pubmed:meshHeadingpubmed-meshheading:15023378...lld:pubmed
pubmed-article:15023378pubmed:meshHeadingpubmed-meshheading:15023378...lld:pubmed
pubmed-article:15023378pubmed:meshHeadingpubmed-meshheading:15023378...lld:pubmed
pubmed-article:15023378pubmed:meshHeadingpubmed-meshheading:15023378...lld:pubmed
pubmed-article:15023378pubmed:meshHeadingpubmed-meshheading:15023378...lld:pubmed
pubmed-article:15023378pubmed:meshHeadingpubmed-meshheading:15023378...lld:pubmed
pubmed-article:15023378pubmed:meshHeadingpubmed-meshheading:15023378...lld:pubmed
pubmed-article:15023378pubmed:meshHeadingpubmed-meshheading:15023378...lld:pubmed
pubmed-article:15023378pubmed:year2004lld:pubmed
pubmed-article:15023378pubmed:articleTitleIntermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo.lld:pubmed
pubmed-article:15023378pubmed:affiliationDepartment of Rheumatology, Institute of Physical Medicine, University Hospital Zurich, Switzerland. daniel.uebelhart@usz.chlld:pubmed
pubmed-article:15023378pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15023378pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15023378pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:15023378pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:15023378pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15023378lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15023378lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15023378lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15023378lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15023378lld:pubmed